1. The study examined the effect of staining primary gastrointestinal (GIT) epithelial tumors with Alcian Blue at different pH levels (1, 1.5, 2, and 2.5) at Muhimbili National Hospital in Tanzania.
2. Alcian Blue stains acidic mucins blue by reacting with carboxylate and sulphonate groups, which are ionized at physiological pH. The study found that positive staining increased with tumor differentiation and most tumors stained positively at pH 2 regardless of location in the GIT.
3. The study recommends using pH 2 instead of the conventional pH of 1 and 2.5 when staining GIT epithelial tumors with Alcian Blue, though poorly differentiated
1) Esophageal cancer is usually discovered late and has a poor overall 5-year prognosis of less than 10%. Even for potentially resectable esophageal cancers, the 5-year survival rate is less than 30%.
2) The most common benign esophageal tumor is leiomyoma, which typically causes dysphagia or hematemesis if large. Squamous cell carcinoma and adenocarcinoma are the most common malignant esophageal tumors.
3) Treatment for esophageal cancer depends on location, size, spread, and cell type. Surgical resection is preferred for lower third cancers without metastases, but long-term survival cannot be predicted. Radiation and chemotherapy provide palliative options
Paragangliomas, also known as glomus tumours, are rare tumours that arise from paraganglionic tissue. They most commonly occur in the middle ear, jugular foramen, and along the vagus nerve. Surgical resection is the primary treatment, but pre-operative embolization and radiotherapy can help reduce tumour size and vascularity. Complete surgical removal is difficult due to the complex anatomy of the skull base and risk of damaging nearby cranial nerves. Adjuvant radiotherapy is often used post-operatively to prevent tumour regrowth. Functionally active tumours can cause issues with blood pressure control and circulatory collapse during and after surgery.
This document summarizes information about benign and malignant tumors of the digestive system. It begins with definitions of tumors in general and differences between benign and malignant tumors. Specific information is provided about common tumors that can occur in different parts of the digestive system, including the stomach, esophagus, intestines, colon, rectum, and liver. The types, characteristics, and images of these tumors are described. Risk factors and symptoms are outlined. The document concludes by emphasizing the importance of early diagnosis and treatment of benign tumors to reduce cancer incidence and increase life expectancy.
This document summarizes various types of pancreatic tumours. It describes pancreatic ductal adenocarcinoma as the most common exocrine pancreatic cancer, accounting for 85% of cases. Risk factors and clinical features are provided. Other exocrine tumours discussed include acinar cell carcinoma, cystic pancreatic neoplasms such as microcystic cystadenoma and mucinous cystadenoma. Neuroendocrine tumours such as insulinomas are also summarized. Rare tumour types like anaplastic carcinoma, giant cell tumour and intraductal papillary mucinous neoplasms are described.
This document discusses endocrine tumors of the gastrointestinal tract, known as carcinoid tumors and pancreatic endocrine tumors (PETs). It covers their classification, characteristics, locations, secretory products, diagnostic tests and treatments. Key points include that carcinoid tumors arise from enterochromaffin cells and PETs arise from islet cells in the pancreas. Diagnosis involves measuring hormone levels and imaging tests. Treatments include surgery, somatostatin analogs, and other drugs depending on the specific tumor type and symptoms.
1. The document discusses gastrointestinal bleeding, describing different types including hematemesis, melena, hematochezia, occult blood, and chronic blood loss.
2. It examines causes of upper and lower GI bleeding such as peptic ulcers, varices, hemorrhoids, and tumors.
3. Evaluation and management are outlined, including resuscitation of hypovolemic shock, determining bleeding location, and considering high risk patients.
The document discusses tumors of the small and large intestines. It classifies intestinal tumors and provides details on various benign and malignant tumor types. The most common tumors are epithelial tumors, with colorectal cancer representing 70% of all gastrointestinal malignancies. Adenomas are precursors to most colorectal cancers. Risk factors include inflammatory bowel disease, familial polyposis, and diet. Prognosis and treatment depend on tumor stage and characteristics.
Gastrointestinal stromal tumors (GISTs) arise from interstitial cells of Cajal in the gastrointestinal tract. Pathogenic mutations in KIT or PDGFRA genes drive tumor growth in most GISTs. GISTs most commonly occur in the stomach and small intestine. Microscopically, GISTs demonstrate spindle or epithelioid cell morphologies and strongly express KIT (CD117). Surgical resection is the primary treatment, while the tyrosine kinase inhibitor imatinib is effective for advanced or metastatic disease. Tumor size, mitotic rate, and site determine prognosis, with small intestinal GISTs having the worst outcomes.
1) Esophageal cancer is usually discovered late and has a poor overall 5-year prognosis of less than 10%. Even for potentially resectable esophageal cancers, the 5-year survival rate is less than 30%.
2) The most common benign esophageal tumor is leiomyoma, which typically causes dysphagia or hematemesis if large. Squamous cell carcinoma and adenocarcinoma are the most common malignant esophageal tumors.
3) Treatment for esophageal cancer depends on location, size, spread, and cell type. Surgical resection is preferred for lower third cancers without metastases, but long-term survival cannot be predicted. Radiation and chemotherapy provide palliative options
Paragangliomas, also known as glomus tumours, are rare tumours that arise from paraganglionic tissue. They most commonly occur in the middle ear, jugular foramen, and along the vagus nerve. Surgical resection is the primary treatment, but pre-operative embolization and radiotherapy can help reduce tumour size and vascularity. Complete surgical removal is difficult due to the complex anatomy of the skull base and risk of damaging nearby cranial nerves. Adjuvant radiotherapy is often used post-operatively to prevent tumour regrowth. Functionally active tumours can cause issues with blood pressure control and circulatory collapse during and after surgery.
This document summarizes information about benign and malignant tumors of the digestive system. It begins with definitions of tumors in general and differences between benign and malignant tumors. Specific information is provided about common tumors that can occur in different parts of the digestive system, including the stomach, esophagus, intestines, colon, rectum, and liver. The types, characteristics, and images of these tumors are described. Risk factors and symptoms are outlined. The document concludes by emphasizing the importance of early diagnosis and treatment of benign tumors to reduce cancer incidence and increase life expectancy.
This document summarizes various types of pancreatic tumours. It describes pancreatic ductal adenocarcinoma as the most common exocrine pancreatic cancer, accounting for 85% of cases. Risk factors and clinical features are provided. Other exocrine tumours discussed include acinar cell carcinoma, cystic pancreatic neoplasms such as microcystic cystadenoma and mucinous cystadenoma. Neuroendocrine tumours such as insulinomas are also summarized. Rare tumour types like anaplastic carcinoma, giant cell tumour and intraductal papillary mucinous neoplasms are described.
This document discusses endocrine tumors of the gastrointestinal tract, known as carcinoid tumors and pancreatic endocrine tumors (PETs). It covers their classification, characteristics, locations, secretory products, diagnostic tests and treatments. Key points include that carcinoid tumors arise from enterochromaffin cells and PETs arise from islet cells in the pancreas. Diagnosis involves measuring hormone levels and imaging tests. Treatments include surgery, somatostatin analogs, and other drugs depending on the specific tumor type and symptoms.
1. The document discusses gastrointestinal bleeding, describing different types including hematemesis, melena, hematochezia, occult blood, and chronic blood loss.
2. It examines causes of upper and lower GI bleeding such as peptic ulcers, varices, hemorrhoids, and tumors.
3. Evaluation and management are outlined, including resuscitation of hypovolemic shock, determining bleeding location, and considering high risk patients.
The document discusses tumors of the small and large intestines. It classifies intestinal tumors and provides details on various benign and malignant tumor types. The most common tumors are epithelial tumors, with colorectal cancer representing 70% of all gastrointestinal malignancies. Adenomas are precursors to most colorectal cancers. Risk factors include inflammatory bowel disease, familial polyposis, and diet. Prognosis and treatment depend on tumor stage and characteristics.
Gastrointestinal stromal tumors (GISTs) arise from interstitial cells of Cajal in the gastrointestinal tract. Pathogenic mutations in KIT or PDGFRA genes drive tumor growth in most GISTs. GISTs most commonly occur in the stomach and small intestine. Microscopically, GISTs demonstrate spindle or epithelioid cell morphologies and strongly express KIT (CD117). Surgical resection is the primary treatment, while the tyrosine kinase inhibitor imatinib is effective for advanced or metastatic disease. Tumor size, mitotic rate, and site determine prognosis, with small intestinal GISTs having the worst outcomes.
Tumours of bones, cartilage & joints mbbs lectDr Neha Mahajan
This document discusses bone tumors, classifying them based on the type of tissue they produce. It describes several benign and malignant bone tumors. Benign bone forming tumors discussed include osteoid osteoma and osteoblastoma. Osteosarcoma is described as the most common primary malignant bone tumor that produces osteoid matrix. Cartilage forming tumors described are osteochondroma, chondroma, chondroblastoma, and chondrosarcoma. Giant cell tumor is discussed as a benign but locally aggressive tumor dominated by multinucleated giant cells. Ewing's sarcoma is summarized as the second most common bone malignancy in children that arises in long bone medullary cavities.
Pancreatic cancer develops from DNA damage to cells in the pancreas that causes uncontrolled growth. Most cases are ductal adenocarcinoma. Risk factors include smoking, obesity, family history, and chronic pancreatitis. Symptoms include jaundice, abdominal pain, weight loss, and fatigue. Diagnosis involves imaging like CT, MRI, and endoscopic ultrasound. Only 20% of cases are surgically resectable; the remainder receive chemotherapy, radiation, or supportive care. Prognosis is generally poor with a median survival of 4-6 months for metastatic disease.
Gastrointerstinal stromal tumor (GIST) recent advances and differential diagn...Indira Shastry
This document provides information on gastrointestinal stromal tumors (GISTs), including:
- GISTs arise from interstitial cells of Cajal in the gastrointestinal tract and are defined by activating mutations in KIT or PDGFRA.
- Common symptoms are nonspecific but most GISTs are found in the stomach.
- Immunohistochemistry shows positivity for CD117 in 95% of cases, as well as DOG1, CD34, and protein kinase C theta.
- Risk stratification systems exist to determine malignant potential and guide treatment, which frequently involves tyrosine kinase inhibitors.
This document provides information on pancreatic adenocarcinoma, including its anatomy, physiology, clinical presentation, investigations, staging, treatment and prognosis. It discusses the exocrine and endocrine functions of the pancreas. It also covers cystic lesions of the pancreas and pancreatic endocrine tumours. The staging and survival rates for pancreatic cancer are presented. Complications of pancreatic surgery and mortality rates at high volume centers are summarized.
Carcinoids are rare neuroendocrine tumors that originate from enterochromaffin cells. They most commonly occur in the gastrointestinal tract and bronchopulmonary system. Carcinoids are classified based on their site of origin and pathological features. Well differentiated carcinoids tend to grow slowly, while poorly differentiated carcinoids are more aggressive. Treatment involves surgical removal of localized tumors. For metastatic disease, treatment focuses on controlling carcinoid syndrome symptoms caused by secreted hormones and peptides. Prognosis depends on tumor stage, grade, and site of origin. Long term monitoring is important after treatment due to the risk of recurrence.
Biological membranes as a barriers to drugs(pH trapping)Freya Cardozo
Transport of drugs across the membrane, Passive Diffusion, carrier mediated, Facilitated, Endocytosis, Ion transport and pH trapping.
Blood brain barrier and(BBB) stratergies to overcome BBB
The document discusses the anatomy, histology, and physiology of the stomach. It describes the three layers of the stomach wall - the submucosa, muscularis, and serosa. It details the three types of gastric glands - mucous, parietal, and chief cells - and their secretions. Parietal cells secrete hydrochloric acid and intrinsic factor. Chief cells secrete pepsinogen and gastric lipase. The stomach's defenses against acid are also summarized, including the mucus barrier and bicarbonate secretion.
i) Peptic ulcers develop in the stomach, esophagus, or duodenum when factors that damage or inhibit the protective mechanisms of the gastric mucosa outweigh the defensive factors. Common causes are H. pylori infection and NSAID use.
ii) Symptoms include abdominal pain, nausea, vomiting, loss of appetite, and bleeding. Complications include bleeding, perforation, and pyloric obstruction.
iii) Treatment involves lifestyle modifications, antibiotics to eradicate H. pylori, and medications like PPIs, H2 blockers, and ulcer protective drugs to promote healing.
This document provides information on plant poisoning, specifically mushroom poisoning and mycotoxins, as well as clinical symptoms and management of acute poisoning from caustics such as inorganic acids and alkalis. It discusses mushroom poisoning in detail, including the types of toxic mushrooms, toxins produced, clinical features, diagnosis and treatment. It also covers mycotoxins commonly produced by fungi, including aflatoxins and trichothecenes. The document concludes by describing sulfuric acid and nitric acid poisoning, their uses, effects, diagnosis and emergency treatment.
This document discusses the differences between ileal and colonic Crohn's disease. It notes that while current guidelines do not differentiate treatment based on location, there are important differences between the two sites in epidemiology, genetics, histology, the intestinal barrier and immune response. Specifically, the mesentery surrounding the inflamed ileum develops changes like creeping fat and lymphoid aggregates that are not seen in the colon. Structurally, the ileum has a single mucus layer while the colon has two, and each site has different microbiota, antimicrobial peptides and immune cell populations even under healthy conditions. In Crohn's disease, both locations see decreases in the mucus layer and microbiota diversity, disruption of the
Chromoendoscopy refers to the application of dyes or stains during endoscopy to enhance tissue characterization. Various dyes can be used to identify epithelial cell types, highlight mucosal topography, or react with cellular constituents. Stains like Lugol's iodine, methylene blue, and toluidine blue have been used to detect abnormalities in the esophagus, stomach, and colon. Studies show these dyes can increase the detection of conditions like Barrett's esophagus, gastric intestinal metaplasia, and dysplasia compared to white light endoscopy alone. The dyes are sprayed onto the mucosa using catheter systems and findings are interpreted after a brief staining period.
Assessment of the immune status of nile tilapia (oreochromis niloticus) exper...sherein abdelgayed
Manal M. Zaki, Alaa E. Eissa, and Sherein Saeid (2011): Assessment of the Immune Status in Nile Tilapia (Oreochromis niloticus) Experimentally Challenged with Toxogenic / Septicemic Bacteria During Treatment Trial with Florfenicol and Enrofloxacin.World Journal of Fish and Marine Sciences(WJFMS)3(1):21-36.
The document discusses the role of gut microbiota in nutrition and health. It makes three key points:
1) The gut microbiota contributes nutrients and energy to the host through fermenting nondigestible dietary components, and maintains a balance with the host's metabolism and immune system in a healthy state.
2) Diet has a major influence on microbial community composition in both the short and long term, opening possibilities for manipulating health through diet.
3) There is significant interindividual variation in gut microbiota composition within populations that influences responses to drugs and diet. Achieving a better understanding of microbiota profiles that support health is important.
ggregatibacter actinomycetemcomitans (previously Actinobacillus actinomycetemcomitans) is a Gram-negative, facultative nonmotile, rod-shaped oral commensal often found in association with localized aggressive periodontitis, a severe infection of the periodontium, although it is also associated with nonoral infections. Its role in periodontitis was first discovered by Danish-born periodontist Jørgen Slots, a professor of dentistry and microbiology at the University of Southern California School of Dentistry.
'Bacterium actinomycetem comitans' was described by Klinger (1912) as coccobacillary bacteria isolated together with Actinomyces from actinomycotic lesions of man. It was reclassified as Actinobacillus actinomycetemcomitans by Topley & Wilson (1929) and as Haemophilus actinomycetemcomitans by Potts et al. (1985). The species has attracted attention because of its association with localized aggressive periodontitis. is explained here by Dr Harshavardhan Patwal
1) The olsA gene mediates the synthesis of ornithine lipids in P. aeruginosa under phosphate-limiting conditions. Ornithine lipids are phosphate-free and their production allows the bacteria to reduce phosphate utilization in its membranes.
2) Mass spectrometry analysis confirmed the production and structure of ornithine lipids in P. aeruginosa, which contain mainly C16:0 and C18:1 fatty acid chains.
3) While resistance to antimicrobial peptides increases under phosphate limitation, ornithine lipid production was found to not be required for this increased resistance or for virulence in a C. elegans infection model.
salivary old new dd.pppptx disease and healthMohamedYElZahar
1. Salivary biomarkers can provide non-invasive alternatives to clinical diagnostics for periodontal diseases by detecting bacterial, host, and inflammatory markers. A combination of biomarkers may provide a more accurate assessment than a single marker.
2. Specific salivary biomarkers for periodontal diseases include immunoglobulins directed against periodontal pathogens, salivary enzymes like lysozyme and peroxidase, and ions like calcium. Nonspecific biomarkers include lactoferrin, histatin, fibronectin, and platelet activating factor.
3. Emerging biomarkers include analysis of the salivary proteome, transcriptome, and host genomic factors that influence susceptibility. However, no single biomarker adequately diagnoses
Pre and probiotics in colorectal cancer Prevention By Dalia Khamis El-DeebDalia Deeb
This document discusses prebiotics, probiotics, and their potential role in preventing colon cancer. It begins with definitions of prebiotics as selectively fermented ingredients that change the gastrointestinal microflora to benefit health. Probiotics are live microorganisms that colonize the intestines and exert beneficial effects. The document explores how gut microbiota can contribute to carcinogenesis and the mechanisms by which probiotics and their short-chain fatty acid products may prevent colon cancer, such as decreasing pH, modulating compounds, and inducing apoptosis in altered cells. It concludes that while studies have shown potential, more research is still needed to fully understand mechanisms and generate conclusive evidence on using prebiotics and probiotics to prevent and manage colon
This document discusses perforated peptic ulcers. It first covers the surgical anatomy and blood supply of the stomach and duodenum. It then discusses the epidemiology, pathophysiology, risk factors, presentation, diagnosis, and treatment of perforated peptic ulcers. Key points include that perforations are more common in duodenal versus gastric ulcers and have a higher mortality rate for gastric ulcers. Risk factors include H. pylori infection, NSAID use, smoking, and Zollinger-Ellison syndrome. Patients typically present with sudden severe abdominal pain. Diagnosis involves upright chest x-rays showing free air. Treatment is surgical repair of the perforation.
This document summarizes current knowledge about microbial biofilms in the gastrointestinal (GI) tract and their association with health and disease. It discusses how the GI tract provides many environments suitable for biofilm formation. Several diseases are implicated as involving GI biofilms, including Barrett's esophagus and Helicobacter pylori infections. Studies have found distinct microbial communities and biofilms in patients with Barrett's esophagus compared to controls. H. pylori is able to form biofilms in the stomach that may help it persist and contribute to diseases like peptic ulcers. Overall, the review examines the composition and potential roles of microbial biofilms throughout the GI tract.
This document discusses atrophic gastritis (AG), including its definition, diagnosis, endoscopic features, histopathology, management, and surveillance recommendations. Key points include: AG is defined as loss of gastric glands due to chronic inflammation, most commonly from H. pylori infection; intestinal metaplasia on biopsy implies AG; endoscopic signs of AG include pale mucosa and loss of folds; surveillance endoscopy is recommended every 3 years for advanced AG; screening for autoimmune disorders and nutritional deficiencies is important in AG management; and coordinated efforts between gastroenterologists and pathologists can improve AG diagnosis and characterization.
1) Adamantyl-tethered-biphenylic compounds were synthesized and found to induce apoptosis in cancer cells.
2) Compound 30-(adamantan-1-yl)-40-methoxy-[1,10-biphenyl]-3-ol (AMB) showed cytotoxic activity against hepatocellular carcinoma cell lines without harming normal cells.
3) AMB was found to target and downregulate anti-apoptotic Bcl-2 family proteins like Bcl-2 and Bcl-xL, leading to cell cycle arrest and induction of apoptosis in cancer cells.
Tumours of bones, cartilage & joints mbbs lectDr Neha Mahajan
This document discusses bone tumors, classifying them based on the type of tissue they produce. It describes several benign and malignant bone tumors. Benign bone forming tumors discussed include osteoid osteoma and osteoblastoma. Osteosarcoma is described as the most common primary malignant bone tumor that produces osteoid matrix. Cartilage forming tumors described are osteochondroma, chondroma, chondroblastoma, and chondrosarcoma. Giant cell tumor is discussed as a benign but locally aggressive tumor dominated by multinucleated giant cells. Ewing's sarcoma is summarized as the second most common bone malignancy in children that arises in long bone medullary cavities.
Pancreatic cancer develops from DNA damage to cells in the pancreas that causes uncontrolled growth. Most cases are ductal adenocarcinoma. Risk factors include smoking, obesity, family history, and chronic pancreatitis. Symptoms include jaundice, abdominal pain, weight loss, and fatigue. Diagnosis involves imaging like CT, MRI, and endoscopic ultrasound. Only 20% of cases are surgically resectable; the remainder receive chemotherapy, radiation, or supportive care. Prognosis is generally poor with a median survival of 4-6 months for metastatic disease.
Gastrointerstinal stromal tumor (GIST) recent advances and differential diagn...Indira Shastry
This document provides information on gastrointestinal stromal tumors (GISTs), including:
- GISTs arise from interstitial cells of Cajal in the gastrointestinal tract and are defined by activating mutations in KIT or PDGFRA.
- Common symptoms are nonspecific but most GISTs are found in the stomach.
- Immunohistochemistry shows positivity for CD117 in 95% of cases, as well as DOG1, CD34, and protein kinase C theta.
- Risk stratification systems exist to determine malignant potential and guide treatment, which frequently involves tyrosine kinase inhibitors.
This document provides information on pancreatic adenocarcinoma, including its anatomy, physiology, clinical presentation, investigations, staging, treatment and prognosis. It discusses the exocrine and endocrine functions of the pancreas. It also covers cystic lesions of the pancreas and pancreatic endocrine tumours. The staging and survival rates for pancreatic cancer are presented. Complications of pancreatic surgery and mortality rates at high volume centers are summarized.
Carcinoids are rare neuroendocrine tumors that originate from enterochromaffin cells. They most commonly occur in the gastrointestinal tract and bronchopulmonary system. Carcinoids are classified based on their site of origin and pathological features. Well differentiated carcinoids tend to grow slowly, while poorly differentiated carcinoids are more aggressive. Treatment involves surgical removal of localized tumors. For metastatic disease, treatment focuses on controlling carcinoid syndrome symptoms caused by secreted hormones and peptides. Prognosis depends on tumor stage, grade, and site of origin. Long term monitoring is important after treatment due to the risk of recurrence.
Biological membranes as a barriers to drugs(pH trapping)Freya Cardozo
Transport of drugs across the membrane, Passive Diffusion, carrier mediated, Facilitated, Endocytosis, Ion transport and pH trapping.
Blood brain barrier and(BBB) stratergies to overcome BBB
The document discusses the anatomy, histology, and physiology of the stomach. It describes the three layers of the stomach wall - the submucosa, muscularis, and serosa. It details the three types of gastric glands - mucous, parietal, and chief cells - and their secretions. Parietal cells secrete hydrochloric acid and intrinsic factor. Chief cells secrete pepsinogen and gastric lipase. The stomach's defenses against acid are also summarized, including the mucus barrier and bicarbonate secretion.
i) Peptic ulcers develop in the stomach, esophagus, or duodenum when factors that damage or inhibit the protective mechanisms of the gastric mucosa outweigh the defensive factors. Common causes are H. pylori infection and NSAID use.
ii) Symptoms include abdominal pain, nausea, vomiting, loss of appetite, and bleeding. Complications include bleeding, perforation, and pyloric obstruction.
iii) Treatment involves lifestyle modifications, antibiotics to eradicate H. pylori, and medications like PPIs, H2 blockers, and ulcer protective drugs to promote healing.
This document provides information on plant poisoning, specifically mushroom poisoning and mycotoxins, as well as clinical symptoms and management of acute poisoning from caustics such as inorganic acids and alkalis. It discusses mushroom poisoning in detail, including the types of toxic mushrooms, toxins produced, clinical features, diagnosis and treatment. It also covers mycotoxins commonly produced by fungi, including aflatoxins and trichothecenes. The document concludes by describing sulfuric acid and nitric acid poisoning, their uses, effects, diagnosis and emergency treatment.
This document discusses the differences between ileal and colonic Crohn's disease. It notes that while current guidelines do not differentiate treatment based on location, there are important differences between the two sites in epidemiology, genetics, histology, the intestinal barrier and immune response. Specifically, the mesentery surrounding the inflamed ileum develops changes like creeping fat and lymphoid aggregates that are not seen in the colon. Structurally, the ileum has a single mucus layer while the colon has two, and each site has different microbiota, antimicrobial peptides and immune cell populations even under healthy conditions. In Crohn's disease, both locations see decreases in the mucus layer and microbiota diversity, disruption of the
Chromoendoscopy refers to the application of dyes or stains during endoscopy to enhance tissue characterization. Various dyes can be used to identify epithelial cell types, highlight mucosal topography, or react with cellular constituents. Stains like Lugol's iodine, methylene blue, and toluidine blue have been used to detect abnormalities in the esophagus, stomach, and colon. Studies show these dyes can increase the detection of conditions like Barrett's esophagus, gastric intestinal metaplasia, and dysplasia compared to white light endoscopy alone. The dyes are sprayed onto the mucosa using catheter systems and findings are interpreted after a brief staining period.
Assessment of the immune status of nile tilapia (oreochromis niloticus) exper...sherein abdelgayed
Manal M. Zaki, Alaa E. Eissa, and Sherein Saeid (2011): Assessment of the Immune Status in Nile Tilapia (Oreochromis niloticus) Experimentally Challenged with Toxogenic / Septicemic Bacteria During Treatment Trial with Florfenicol and Enrofloxacin.World Journal of Fish and Marine Sciences(WJFMS)3(1):21-36.
The document discusses the role of gut microbiota in nutrition and health. It makes three key points:
1) The gut microbiota contributes nutrients and energy to the host through fermenting nondigestible dietary components, and maintains a balance with the host's metabolism and immune system in a healthy state.
2) Diet has a major influence on microbial community composition in both the short and long term, opening possibilities for manipulating health through diet.
3) There is significant interindividual variation in gut microbiota composition within populations that influences responses to drugs and diet. Achieving a better understanding of microbiota profiles that support health is important.
ggregatibacter actinomycetemcomitans (previously Actinobacillus actinomycetemcomitans) is a Gram-negative, facultative nonmotile, rod-shaped oral commensal often found in association with localized aggressive periodontitis, a severe infection of the periodontium, although it is also associated with nonoral infections. Its role in periodontitis was first discovered by Danish-born periodontist Jørgen Slots, a professor of dentistry and microbiology at the University of Southern California School of Dentistry.
'Bacterium actinomycetem comitans' was described by Klinger (1912) as coccobacillary bacteria isolated together with Actinomyces from actinomycotic lesions of man. It was reclassified as Actinobacillus actinomycetemcomitans by Topley & Wilson (1929) and as Haemophilus actinomycetemcomitans by Potts et al. (1985). The species has attracted attention because of its association with localized aggressive periodontitis. is explained here by Dr Harshavardhan Patwal
1) The olsA gene mediates the synthesis of ornithine lipids in P. aeruginosa under phosphate-limiting conditions. Ornithine lipids are phosphate-free and their production allows the bacteria to reduce phosphate utilization in its membranes.
2) Mass spectrometry analysis confirmed the production and structure of ornithine lipids in P. aeruginosa, which contain mainly C16:0 and C18:1 fatty acid chains.
3) While resistance to antimicrobial peptides increases under phosphate limitation, ornithine lipid production was found to not be required for this increased resistance or for virulence in a C. elegans infection model.
salivary old new dd.pppptx disease and healthMohamedYElZahar
1. Salivary biomarkers can provide non-invasive alternatives to clinical diagnostics for periodontal diseases by detecting bacterial, host, and inflammatory markers. A combination of biomarkers may provide a more accurate assessment than a single marker.
2. Specific salivary biomarkers for periodontal diseases include immunoglobulins directed against periodontal pathogens, salivary enzymes like lysozyme and peroxidase, and ions like calcium. Nonspecific biomarkers include lactoferrin, histatin, fibronectin, and platelet activating factor.
3. Emerging biomarkers include analysis of the salivary proteome, transcriptome, and host genomic factors that influence susceptibility. However, no single biomarker adequately diagnoses
Pre and probiotics in colorectal cancer Prevention By Dalia Khamis El-DeebDalia Deeb
This document discusses prebiotics, probiotics, and their potential role in preventing colon cancer. It begins with definitions of prebiotics as selectively fermented ingredients that change the gastrointestinal microflora to benefit health. Probiotics are live microorganisms that colonize the intestines and exert beneficial effects. The document explores how gut microbiota can contribute to carcinogenesis and the mechanisms by which probiotics and their short-chain fatty acid products may prevent colon cancer, such as decreasing pH, modulating compounds, and inducing apoptosis in altered cells. It concludes that while studies have shown potential, more research is still needed to fully understand mechanisms and generate conclusive evidence on using prebiotics and probiotics to prevent and manage colon
This document discusses perforated peptic ulcers. It first covers the surgical anatomy and blood supply of the stomach and duodenum. It then discusses the epidemiology, pathophysiology, risk factors, presentation, diagnosis, and treatment of perforated peptic ulcers. Key points include that perforations are more common in duodenal versus gastric ulcers and have a higher mortality rate for gastric ulcers. Risk factors include H. pylori infection, NSAID use, smoking, and Zollinger-Ellison syndrome. Patients typically present with sudden severe abdominal pain. Diagnosis involves upright chest x-rays showing free air. Treatment is surgical repair of the perforation.
This document summarizes current knowledge about microbial biofilms in the gastrointestinal (GI) tract and their association with health and disease. It discusses how the GI tract provides many environments suitable for biofilm formation. Several diseases are implicated as involving GI biofilms, including Barrett's esophagus and Helicobacter pylori infections. Studies have found distinct microbial communities and biofilms in patients with Barrett's esophagus compared to controls. H. pylori is able to form biofilms in the stomach that may help it persist and contribute to diseases like peptic ulcers. Overall, the review examines the composition and potential roles of microbial biofilms throughout the GI tract.
This document discusses atrophic gastritis (AG), including its definition, diagnosis, endoscopic features, histopathology, management, and surveillance recommendations. Key points include: AG is defined as loss of gastric glands due to chronic inflammation, most commonly from H. pylori infection; intestinal metaplasia on biopsy implies AG; endoscopic signs of AG include pale mucosa and loss of folds; surveillance endoscopy is recommended every 3 years for advanced AG; screening for autoimmune disorders and nutritional deficiencies is important in AG management; and coordinated efforts between gastroenterologists and pathologists can improve AG diagnosis and characterization.
1) Adamantyl-tethered-biphenylic compounds were synthesized and found to induce apoptosis in cancer cells.
2) Compound 30-(adamantan-1-yl)-40-methoxy-[1,10-biphenyl]-3-ol (AMB) showed cytotoxic activity against hepatocellular carcinoma cell lines without harming normal cells.
3) AMB was found to target and downregulate anti-apoptotic Bcl-2 family proteins like Bcl-2 and Bcl-xL, leading to cell cycle arrest and induction of apoptosis in cancer cells.
Moving into the Post-MetagenomicEra of Gut Microbiome ResearchJonathan Clarke
Julian Marchesi's presentation slides from our previous Microbiome R&D and Business Collaboration Forum. For information about this years event please visit http://www.globalengage.co.uk/microbiota.html
This document studies the effects of sporamin, a protein from sweet potatoes, on human gut cancer cell lines. It finds that sporamin exerts significant anti-proliferative and anti-metastatic effects by inducing apoptosis in human pancreatic, esophageal, and colorectal cancer cell lines. Specifically, sporamin treatment was found to suppress tumor growth through influencing expression of Bcl-2 family proteins and inhibiting the NF-κB pathway. Figures 1-3 show results of experiments demonstrating sporamin's dose-dependent inhibition of cancer cell proliferation and induction of apoptosis.
Probiotics are live microorganisms that confer health benefits when colonize the gastrointestinal tract. The various microbial strains are now found to provide therapeutic effects through the metabolites they produce, digestion of dietary fibers, inhibition of pathogen adhesion, provide missing enzyme, maintaining homeostasis and also controlling brain activities which may lead to autism if disturbed.
Vibrio cholerae. Genera Vibrio. Treatment of choleraeEneutron
This document discusses the biological characteristics, diagnostics, control and treatment of Vibrio cholerae, the bacteria that causes cholera. It covers the taxonomy, morphology, cultural characteristics, virulence factors and epidemiology of V. cholerae. It also discusses laboratory diagnosis of cholera including microscopy, culture-based methods and serological testing. Treatment involves oral rehydration therapy and antibiotics. The document also briefly discusses other Vibrio species including V. parahaemolyticus, an enteropathogenic bacteria associated with food poisoning from marine food.
Vibrio cholerae. Genera Vibrio. Treatment of cholerae
AB Publication
1. Professional Med J 2014;21(6): 1251-1257 www.theprofessional.com
ALCIAN BLUE pH
1251
The Professional Medical Journal
www.theprofesional.com
ALCIAN BLUE pH;
THE EFFECT OF STAINING FOR PRIMARY GIT EPITHELIAL TUMOURS IN
PATIENTS DIAGNOSED AT MUHIMBILI NATIONAL HOSPITAL, TANZANIA
Dr. Henry A Mwakyoma1
, Mr. Ponsianus T. Tonya2
ORIGINAL PROF-2380
ABSTRACT: Background: Alcian blue (AB) is a cationic dye that stains mucins especially acidic
mucins into varying shades of blue colour depending on the pH of the dye. GIT comprises
of three main portions, fore-, mid- and hind-gut, which develops from different embryological
areas. Their epithelial lining presents with varying degree of diversity including their secretions.
Studies have shown that there is a tendency of cellular modification (physical and chemical)
including secretions during tumour morphogenesis. With recent increase in GIT tumours
especially epithelial tumours, Alcian Blue staining of mucins produced by these tumours at
different pH more than conventional pH might give valuable information on the property of
these tumours. Setting: The study was conducted in the Histopathology and Morbid Anatomy
unit, department of Laboratory services, Muhimbili National Hospital, Tanzania. Study design:
This was a hospital based retrospective study, in which archival data and blocks were retrieved.
Objective: To determine the effect of pH and pattern of Alcian blue staining on primary GIT
epithelial tumours tumours. Materials and Methods: Information on patients were obtained
from cancer registry and patient files. Paraffin blocks were retrieved from archive, sections were
cut using rotary microtome at 3µm (SAKURA). Haematoxylin and Eosin (H&E) and AB staining
at pH 1, 1.5, 2 and 2.5 was done for each case and control. H&E slides were reviewed for
confirmation of the diagnosis primary epithelial tumours and AB stained slides were evaluated
for staining reaction and graded. Results: Out of 87 GIT primary epithelial tumours which were
evaluated, AB staining was positive in 21 (24.1%) cases, the majority of these (11 (52.4%)) were
from hindgut. Positive AB staining of GIT epithelial tumours increased as the tumour became
more differentiated irrespective of location. Majority of tumours with positive AB staining was
observed at pH 2 in GIT epithelial tumours as opposed to the conventional pH of 1 and 2.5
respectively. Conclusions and recommendation: The majority of primary GIT epithelial
tumours stained positively at pH 2 irrespective of the location. However tumour differentiation
influenced AB staining whereby well-differentiated tumours were mostly positively stained. It is
recommended that AB at pH 2 should be applied when staining GIT epithelial tumours rather
than conventional pH of 1 and 2.5. However the degree of differentiation should be considered
since poorly differentiated tumours are likely to give negative results with AB staining.
Key words: Alcian Blue, pH, Staining, GIT Tumours
1. MD, MSc, MMed
Senior Lecturer
Department of Pathology
MUHIMBILI University of Health and
Allied Sciences
P.O Box 65001, Dar es Salaam,
TANZANIA.
2. BMLS (Histotechnologist)
Pathology Unit, Department of
Laboratory services
Muhimbili National Hospital
P.O Box 65002, Dar es Salaam,
TANZANIA
Correspondence Address:
Dr. Henry A. Mwakyoma
MD, MSc, MMed
Senior Lecturer
Department of Pathology
MUHIMBILI University of Health and
Allied Sciences
P.O Box 65001, Dar es Salaam,
TANZANIA.
hmwakyoma@yohoo.com
Article received on:
28/10/2013
Accepted for publication:
10/09/2014
Received after proof reading:
15/12/2014
Article Citation: Mwakyoma HA, Tonya PT. Alcian blue pH: The effect of staining for primary
GIT epithelial tumours in patients diagnosed at Muhimbili National Hospital,
Tanzania. Professional Med J 2014; 21(6):1251-1257.
INTRODUCTION
Alcian Blue (AB) is large conjugated dye molecule
that initially was used for the dying of textile fibers.
It is comprised of central copper containing
pthalocynine ring linked to Isothiouronium
groups via thioester bonds. The Isothiouronium
are moderately strong bases and account for
the cationic nature of AB, and therefore reaction
with anionic groups1
. The reaction of AB merely
depends on the pH of surrounding environment.
A variety of different AB dyes have been produced
in the past, but for histopathology laboratory, AB
8G (formerly AB 8Gx) is recommended.
Embryologically, GIT develops from three different
areas and hence divided into foregut, midgut
and hindgut. Foregut includes oesophagus,
stomach, first and second part of duodenum and
they develop from primitive foregut of yolksac.
Midgut which develops from vitello-intestinal
duct, includes third and fourth part of duodenum,
jejunum, ileum, caecum, appendix and
ascending and transverse colons. The hindgut
which develops from primitive hindgut, includes
2. Professional Med J 2014;21(6): 1251-1257 www.theprofessional.com
ALCIAN BLUE pH
1252
2
descending and sigmoid colons, rectum and
upper two third of anal canal2
. These areas are
lined by different epithelia and produce mucins
of varying chemical properties, it is interesting
to understand the pattern of staining of these
mucins and if these pattern is retained or modified
in primary GIT epithelial tumours.
Mucins are high molecular weight glycoproteins
that are found dispersed throughout the epithelia
of GIT, respiratory and reproductive tract. Mucins
are composed of a central protein core with
multiple chains of carbohydrates attached.
Protein core contain a high content of the amino
acid serine and threonine. A defining structure of
the mucins is the presence of tandem repeats of
specific amino acid sequences within the protein
core. From molecular perspective, mucins are
categorized into distinct families (Muc 1, Muc 2,
Muc 3 etc) based upon difference in the sequence
and size of the tandem repeats.
Histochemical reactivity is dependent largely
upon the carbohydrate composition of the mucins
and not protein core. Histochemically, mucins
are classified into neutral mucins and acidic
mucins. Acidic mucins contain carbohydrate
with carboxylate or sulphonate groups. Both
of these groups are ionized at physiologic pH
to produce an overall negative charge of these
mucins. Carbohydrates of neutral mucins lack
acidic groups and thus carry no net charge, they
are found primarily on the surface epithelia of
stomach, Brunner’s glands of duodenum and
in prostatic epithelium. The acid mucins are
found widely distributed throughout the GIT and
respiratory tract.
Expression of mucins is a property of epithelial cell
types that exist in relatively harsh environments.
Mucin’s key characteristic is its ability to form
gels; therefore they are a key component in most
gel-like secretions, serving functions such as
lubrication, cell signaling and forming chemical
barriers3
. In addition, mucins also communicate
the information of the external environment to
the epithelial cells via cellular signalling through
membrane-anchored mucins.
Mucus provides a protective barrier against
pathogens and toxins and contributes to the
innate defensive system in mucosal immunology.
It has been shown that mucins play a role in the
processes of tumour progression, invasion and
metastasis and also in tumour cell survival and
protection against the host immune response2,4
.
Tumours, especially malignant tumours have a
tendency to modify cellular properties and their
products5,6,15,16
including physical and chemical
properties of native cells from which they develop.
Malignant tumours of the gastro-intestinal tract are
not as rare as previous studies suggest. Recent
studies have indicated increasing incidence7
,
where malignant epithelial tumours is leading in
its occurrence than other types like sarcomas,
carcinoid tumour, Non Hodgkin Lymphoma etc7,8
,
it follows therefore that, proper understanding
of malignant epithelial tumours of GIT is of
paramount importance.
Studies have shown that, there is a tendency
of increased production of sialomucins in
various pathological conditions, with decreased
O-acetylation as a common early feature of
malignant and premalignant epithelial disorders,
particularly in colon. This has been demonstrated
both histochemically and biochemically in
colorectal cancer, ulcerative colitis and in colonic
adenoma1,3,5,6
.
Staining of mucins especially in epithelial
tumours, can add valuable information in the
characterization of these tumours. A number of
histochemical techniques can be used to stain
and characterize these mucins. Commonly used
mucin special stains include AB, mucicarmine,
colloidal iron and PAS. Mucicarmine, colloidal iron
and AB stains acidic mucins because they react
with carboxylate or sulphonate group, hence stain
mainly mucin of epithelial origin, conversely to
PAS, which stain both acidic and neutral mucins
apart from other glycoproteins and carbohydrates.
For the sake of this study, AB will be used at
different pH and evaluate the effect especially for
intracellular . AB staining is capable of detecting
sulfomucins and sialomucins but not neutral
3. Professional Med J 2014;21(6): 1251-1257 www.theprofessional.com
ALCIAN BLUE pH
1253
3
mucins, which is mainly found on the surface of
epithelium. The carboxylated sialomucins do not
demonstrate the same magnitude of acidity as
the sulfomucins as these are known to stain over
a long range of pH9,10
, as a result these groups
are not capable of ionization at a pH of 1 or less.
The sialomucins therefore are not charged at this
pH1. Conversely, sulfomucins are ionized and
negatively charged at pH1. It follows that, staining
with AB at pH1, is predominantly due to sulfate
groups among mucins9,10,11
. Tissues known to
stain positive with AB at pH1 includes cartilage,
goblet cells mucins of the large intestines and
the mucins of the bronchial serous glands. Acidic
epithelial mucins like sialomucins and sulfomucins
from large intestines are reactive at pH 2.5.
Neutral mucins like those in gastric mucosa and
Brunner’s glands are not reactive with AB and are
mainly found on the surface epithelium, which is
beyond the scope of this study. This shows that,
mucin produced in different parts of the GIT in
normal and abnormal conditions, tends to behave
differently12,13,15,16
.
It is known that, mucins produced in the GIT
present with varying degree of properties; this is
true because these cells develops from different
part from embryological point of view. An increase
in the GIT tumour prevalence has been noted in
past few years most especially, epithelial tumours
which are associated with production of mucin.
These tumours have a tendency to modify cellular
properties and their products5,6
including physical
and chemical properties of native cells from which
they develop. It is important to characterize these
tumour properly including mucins they secretes.
There is a need to characterize mucins produced
by GIT epithelial tumours to understand whether
AB staining pattern at convectional pH of 1 and
2.5 is retained or is changed and at which pH
these mucins stain positively. This will help to
understand and properly characterize these
tumours into fore-, mid- and hind-gut in the GIT
using simple and cost effective technique, for low
resource country like Tanzania. Understanding
specific pH at which particular tumours stain
necessitated introduction of other pH ranges
rather than using the convectional pH of 1 and
2.5 only. Immunohistochemistry or combination
of techniques for mucins was not considered
because of cost and time of the study. Staining
GIT primary epithelial tumours with varying pH
of AB dye, can give valuable information in the
characterization of these tumours
MATERIALS AND METHODS
The objective of the study was to determine the
effect of pH and pattern of Alcian blue staining on
primary GIT epithelial tumours and characterize
them in relation to location (fore-, mid, and hind-
gut).
The study was a hospital based retrospective
study, in which archival data and blocks were
retrieved which was conducted in Histopathology
and Morbid Anatomy unit, department of
Laboratory services, Muhimbili National Hospital,
Tanzania from 2010 to 2012.
The information on patients were obtained
from cancer registry and patient files. The
blocks from 88 patients diagnosed to have GIT
primary epithelial tumour were taken as cases
and 40 blocks with non tumourous conditions
like inflammation were regarded as “normal”.
Appendix following appendectomy of non
tumourous patient was taken as external control
for AB at pH 1 and transverse colon without a
tumour as external control for pH 2.5. Thereafter
blocks were retrieved from archive, sections were
cut with rotary microtome at 3m (SAKURA) and
Haematoxylin and Eosin (H&E) and AB staining
at pH 1, 1.5, 2 and 2.5 was done for each case
and control. H&E slides were reviewed by a
pathologist for confirmation of the diagnosis
primary epithelial tumours and AB stained slides
were evaluated for staining reaction and graded.
Data Collection and Analysis
Data collection was done in designed structured
in tables. Microscopy to determine AB staining of
glandular cell mucins was done independently
by a histotechnologist and pathologist, where
pathologist grading was regarded as gold
standard. AB staining was grouped into positive
4. Professional Med J 2014;21(6): 1251-1257 www.theprofessional.com
ALCIAN BLUE pH
1254
4
and negative, where positive cases were graded
as mild (+) for pale blue staining, moderate (++)
for blue staining and strong (+++) for deep blue
staining while negative cases were those without
intracellular epithelial AB staining. The intense
staining was taken as the best pH at which the
case stained.
Ethical issues
Permission to access blocks and patient files,
use of machines and other materials was sought
from Head of Histopathology Unit. Also ethical
clearance was sought from Muhimbili University
of Health and Allied Sciences (MUHAS) ethical
clearance committee.
pH meter measurement.
pH solution was measured with a pH meter
Consort C830 a mult parameter analyzer
(manufactured by Consort Electrophoresis power
supplies, Tumhout, Belgium) which measures
pH in two decimal places. Before AB solution
pH measurements, the pH electrode previously
stored in KCL solution was then rinsed in a
beaker containing distilled water and thereafter,
the electrode was immersed in a container
that contained raw AB solution and the pH was
recorded
Microtomy
Sections of 3µm were cut from paraffin blocks
cooled on ice blocks, using rotary microtome
(SAKURA Model SRM 200 CW), where four (4)
sections were cut per block, then sections floated
on water bath at 45o
C, mounted on standard
frosted glass slides each labeled with ID number
and respective pH to be stained. Slides were
allowed to drain before being put on hot plate at
60oC for 15 min.
ALCIAN BLUE (AB) Staining procedure
The AB staining at varying pH was made using
the following combination of reagents
Reagents
AB pH 2.5
• Alcian blue 8GX……….. 5.0g
• 3% Acetic acid solution…. 100ml
AB pH 2.0
• Alcian blue 8GX ……………. 5.0g
• 3% Acetic acid ……………….. 100ml
AB pH 1.5
• Alcian blue 8GX …………….. 5.0g
• 0.1N Hydrochloric acid ………. 100ml
AB pH 1
• Alcian blue 8GX …………….. 5.0g
• 0.1N Hydrochloric acid ………. 100ml
Weighing scale (ADAM) was used to measure
alcian blue powder and pH was measured by
pH meter (CONSORT C830) and adjusted using
glacial acetic acid, potassium hydroxide and
hydrochloric acid as required.
Sections were dewaxed and brought down
to distilled water. Sections were dipped in AB
stain of appropriate pH for 30minutes following
mordanting in 3% acetic acid for pH 2.5 and 2
or 0.1N Hydrochloric acid for pH 1 and 1.5, then
washed in water, counterstained with Neutral
red for 5 minutes, washed in water, dehydrated,
cleared and mounted using automated mounting
machine.
Slides were examined using light microscope,
where first the controls slides were examined to
assess the technique and staining results and
then the staining of tumour cases and normal
epithelium was examined for quality and intensity
of staining, whereby the intensity of positive results
was graded into + for mild, ++ for moderate and
+++ for strong AB staining.
RESULTS
The study comprised of 88 epithelial malignant
tumour cases from GIT, diagnosed based on H/E
staining. There were no cases of benign tumour in
this study. Out of 88 GIT tumour cases 75 (85.2%)
were adenocarcinoma and 13 cases (14.8%) were
other malignant epithelial tumours especially
squamous cell carcinoma. Histomorphological
diagnoses showed that 35 (39.8%) of these
tumour were well differentiated in which 26 were
adenocarcinomas, 8 squamous cell carcinomas
and 1 carcinoid tumour. Twenty eight (28),
(31.8%) were moderately differentiated which
consisted of 26 adenocarcinoma and 2 squamous
5. Professional Med J 2014;21(6): 1251-1257 www.theprofessional.com
ALCIAN BLUE pH
1255
cell carcinoma and 25 (28.4%) were poorly
differentiated in which 23 were adenocarcinoma
and 2 squamous cell carcinoma.
Forty two (42) cases were from foregut of
which 31 were adenocarcinoma and 11 other
epithelial tumours particularly squamous cell
carcinoma, 15 cases from midgut out of which
13 were adenocarcinoma and 2 squamous cell
carcinoma and 31 cases found in hindgut were all
adenocarcinomas.
Fifty seven (57), (64.8%) cases were male
patients and 31 (35.2%) female patients. The age
ranged from 1day to 93years, with large group
of patients aged 30 to 80 years Of the 38 GIT
“normal” cases without tumour were regarded as
controls and stained with AB at varying pH; 11
were from foregut, 14 from midgut and 13 from
hindgut. Of 38 GIT controls studied, 25 (65.8%)
stained positively, and out of these 22(88.0%)
stained intensely at pH 2 and 3(12.0%) stained
intensely at pH 2.5. There was no staining on
foregut “normal” tissues (Table I)
Of 87 primary GIT epithelial tumour cases studied
only 21 (24.1%) were positively stained with AB,
of these 11(52.4%) were from hindgut, 4(19.0%)
from midgut and 6(28.6%) from foregut especially
from epithelial tumours of the secretory part.
Majority (18(85.7%)) of GIT epithelial tumour
cases stained with AB intensely at pH 2 (Table II).
Regarding the degree of differentiation of
tumours, 13 (62.0%) which stained positively with
AB were well differentiated and 4 (19.0%) were
moderate and poor differentiated. There was an
increase in the number of cases stained with AB
as differentiation of tumours decreased from well
to poor (Table III).
5
Staining intensity (pH)
1 1.5 2 2.5
Location + ++ +++ + ++ +++ + ++ +++ + ++ +++ -ve +ve
Foregut - - - - - - - - - - - - 11 0
Midgut - - - - - - - 3 8 1 - 1 1 13(92.9%)
Hindgut - - - - - - - 3 8 - - 1 1 12(92.3%)
Subtotal - - - - - - - 6 16 1 - 2 13
Grand Total 0 0 22 3 13 25(65.8%)
Table-I. Staining intensity of “normal” GIT epithelium in relation to pH
“Normal”: - controls
Staining intensity (pH)
1 1.5 2 2.5
Location/
Tumour
+ ++ +++ + ++ +++ + ++ +++ + ++ +++ -ve +ve
Foregut - - - - - - 2 3 - 1 - - 35 6(14.6%)
Midgut - - - - - - 1 3 - - - - 11 4(26.7%)
Hindgut - - - - - - 4 3 2 2 - - 20 11(26.8%)
Subtotal - - - - - - 7 9 2 3 - - 66 21(24.1%)
Grand Total 0 0 18 3 66 21
Table-II. Intensity of AB staining of primary GIT tumours according to location at varying pH
* Carcinoid tumour not included
6. Professional Med J 2014;21(6): 1251-1257 www.theprofessional.com
ALCIAN BLUE pH
1256
DISCUSSION
Alcian Blue (AB) staining of controls (“normal”) of
GIT epithelium was consistent with the expected
normal GIT staining pattern, however the staining
intensity showed that, majority of “normal”
epithelium (88 %), stained at pH 2, this finding can
be explained by the facts that “normal” epithelium
in this study was taken from non tumourous
conditions like inflammatory diseases. This might
have affected the outcome of staining.
AB staining of GIT primary epithelial tumours
were positive only for 21 (24.1%) cases, of these
11 (52.4%) were from hindgut, 4(19.0%) from
midgut and 6(28.6%) from foregut. This shows
that there were more AB staining of GIT tumour
cases observed in hindgut than other sites,
although this might have been attributed to the
number of tumour cases studied in each location.
Also the predominance acidic mucin produced
in hindgut as compared to midgut which has
a mixture of both neutral and acidic mucin and
also predominance of neutral mucin produced
from foregut may be a characteristic nature of the
respective location which is retained in tumours
arising from these sites.
The staining pattern for the majority of GIT
primary epithelial tumours were observed to stain
intensely at pH 2, this might have been attributed
to the fact that most of tumours were preceded
by inflammation which could have changed the
physiochemical nature of mucin secreted. These
findings is supported by other studies5
, who
found in their study that inflammation and other
pre malignant conditions increased production
of sialomucins with decreased O-acetylation
therefore changing physiochemical nature of
mucin produced.
Regarding the degree of differentiation, majority of
well differentiated GIT primary epithelial tumours
13 (62.0%) positively stained with AB while
4(26.7%) and 6(14.6%) were found in midgut and
foregut respectively. This might be explained by
the fact that, well differentiated tumours retain
a significant number of their normal genes and
therefore express the same physiochemical and
genetic characteristics during tumorigenesis.
Despite more positive results with well
differentiated tumours compared to poor and
moderate differentiated tumours, a significant
number of cases were stained negatively with AB.
This might be explained by the facts that, during
tumorigenesis the switch off mechanism for genes
controlling mucin production occurred very early,
hence physiochemically the tumour cells failed to
secrete mucin. Furthermore; molecular changes
of genes that control protein core of mucin may
have played a big role toward this finding as
supported by previous studies1,15,16
.
CONCLUSION AND RECOMMENDATION
The majority of primary GIT epithelial tumours
stained positively at pH 2 irrespective of the
location. However the tumour differentiation
influenced AB staining, whereby well differentiated
Differentiation
Location PD MD WD Total
-ve +ve -ve +ve -ve +ve -ve +ve
Foregut 9 1(10.0%) 13 1(7.1%) 13 4(22.2%) 35 5
Midgut 4 1(20.0%) 4 1(20.0%) 3 2(40.0%) 11 4
Hindgut 3 2(40.0%) 7 2(22.2%) 10 7(41.2%) 20 11
Total 16 4(19.0%) 24 4(19.0%) 27 13(62.0%) 66 21
Table-III. AB staining of GIT primary tumours in relation to Location and Differentiation
*Carcinoid tumour not included.
Key:
WD: Well differentiated MD: Moderately differentiated PD: Poorly differentiated
+: Mild AB staining ++: Moderate AB staining +++: Strong AB staining
+ve: Positive results with AB staining -ve: Negative results with AB staining
6